- ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
Study of DFF332 alone and in combination with Everolimus or Immuno-oncology therapies in patients with renal cell carcinoma and other selected tumors.
This early-stage study is looking at a new medicine, DFF332, by itself or with other treatments, for advanced kidney cancer. It's for adults whose cancer has come back or spread, and aims to see if the new medicine is safe and how it works.
Czechia · Spain · France - authorisedHuman Pharmacology (Phase I)- First administration to humans
A study to test different doses of BI 3923948 alone and in combination with an anti-PD-1 antibody in people with different types of advanced cancer (solid tumors)
This study is testing a new medicine, BI 3923948, on its own and with another cancer drug (an anti-PD-1 antibody). It's for adults with advanced cancers that have spread or can't be removed, to see how safe it is and how different doses work.
Sweden · France · Spain